Clinical Trial Update: Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients

View source ↗

Summary

Post-marketing surveillance study assessing the safety and usage of Byetta (exenatide) in Filipino patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BYETTA (Exenatide)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED